Recent research demonstrates that the ratio of abdominal fat to peripheral fat is a significant independent predictor of cancer.
Browsing: Taxonomy > Pathology and cancer biology
In this review, the authors provide an overview of the physicochemical properties, toxicity and theranostic applications of MNPs with a focus on magnetic iron oxide nanoparticles.
Combinations of conventional and new drugs have been found to enhance the rate of tumor cell death during a study resolving the role of CDKs in esophageal tumor cell mortality.
A novel combination therapy has produced cancer vaccinations in mice involved in a proof-of-concept study.
Research into the PD-L1 pathway has discovered a novel protein known as CMTM6, which binds to PD-L1 on T cell surfaces and enhances PD-L1’s ability to inhibit T cell immune responses. The findings may offer a novel immunotherapy target for many types of cancer.
Novel research has indicated a distinct group of circulating tumor cells that are associated with breast cancer brain metastases, the findings may help detect the tumors while they are still treatable.
In this paper the researchers synthesized M1 and studied its in vivo antiproliferative effects in liver carcinogenic rats. To observe the effects of M1, various studies were conducted including biochemical parameters of plasma and serum, histopathology of liver and HPLC analysis of plasma.
A recent study led by researchers at Dartmouth-Hitchcock Medical Center (NH, USA) has demonstrated that aging normal breast tissues exhibit epigenetic changes that may contribute to the known increased risk of breast cancer with age.
Researchers have shed light on the mechanism by which cyclooxygenase-2 expression potentially drives immune suppression in tumors.
A recent study lead by researchers at Massachusetts General Hospital (MA, USA) has highlighted a novel mechanism behind resistance to angiogenesis inhibitors.